
































![]()
Croda International Plc (COIHY) Q1 2026 Sales/Trading Call April 22, 2026 2:30 AM EDT
Company Participants
Steve Foots - Group Chief Executive & Executive Director
Stephen Oxley - CFO & Executive Director
Conference Call Participants
Matthew Yates - BofA Securities, Research Division
Charles Eden - UBS Investment Bank, Research Division
Katie Richards - Barclays Bank PLC, Research Division
Ming Tang - BNP Paribas, Research Division
Sebastian Bray - Joh. Berenberg, Gossler & Co. KG, Research Division
Artem Chubarov - Rothschild & Co Redburn, Research Division
Lisa Hortense De Neve - Morgan Stanley, Research Division
Chetan Udeshi - JPMorgan Chase & Co, Research Division
Georgina Iwamoto - Goldman Sachs Group, Inc., Research Division
Ranulf Orr - Citigroup Inc., Research Division
Presentation
Operator
Hello, and welcome to the Croda International Q1 2026 Sales Update Call. Please note, this call is being recorded. [Operator Instructions]
I will now hand you over to your host, Steve Foots, to begin today's conference. Please go ahead, sir.
Steve Foots
Group Chief Executive & Executive Director
Good morning, everyone. Many thanks for joining. So I'm here with Stephen and David, and together, happy to take your questions.
So first, just a few overview comments from me. Overall, quarter 1 sales were as we expected it, up 1% at constant currency and similar to a very strong quarter last year. And whilst we acknowledge the heightened uncertainty that the Middle East conflict has caused, it had no material effect on quarter 1, and there is no change to guidance for full year '26.
So breaking our quarter 1 sales performance down by business, sales were up 4% in Consumer Care, driven by Beauty Actives and F&F. Life Sciences saw sales dip 3%, largely due to Crop Protection being 8% lower versus a strong prior year when we saw significant restocking. And industrial sales were down 2%, again against a strong prior period.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。